The shift of cancer metabolism from glycolysis to mitochondrial oxidative phosphorylation is associated with the development of resistance to chemotherapy, and this process seems to be promoted by the enhancement of SIRT1/PCG1α-driven ROS scavenging defences40. The gene discussed is SIRT1; the disease is cancer.